HMR-1426
HMR-1426 is gastric emptying inhibitor potentially for the treatment of obesity. In one study, HMR1426 showed an anorectic potential in rats and decreased body weight and fat mass. This was achieved solely by reducing food intake without influencing overall energy expenditure or behavior suggesting a peripheral mode of action. Thus, HMR1426 can be considered a potential new drug for obesity treatment.
| Supplier | Ace Therapeutics |
|---|---|
| Product # | SMD033 |
| CAS # | 262376-75-0 |
| Pricing | Customizable size, Inquiry |
| Synonym | HMR-1426; HMR1426; HMR 1426; 1426 |
| Product Category | Lab-use Small Molecule Drugs |
| Chemical Formula | C16H12ClNOS |
| Exact Mass | 301.03 |
| Molecular Weight | 301.79 |
| Elemental Analysis | C, 63.68; H, 4.01; Cl, 11.75; N, 4.64; O, 5.30; S, 10.62 |
| IUPAC/Chemical Name | 6-chloro-2-phenyl-8,8a-dihydro-3aH-indeno[1,2-d]thiazol-3a-ol |
| InChi Key | RUBKYBIDEVUTQU-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C16H12ClNOS/c17-12-6-7-13-11(8-12)9-14-16(13,19)18-15(20-14)10-4-2-1-3-5-10/h1-8,14,19H,9H2 |
| SMILES Code | ClC(C=C1)=CC2=C1C(N=C(C3=CC=CC=C3)S4)(O)C4C2 |
| Appearance | Solid powder |
| Purity | >98% (or refer to the Certificate of Analysis) |
| Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. |
| Storage Condition | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
| Solubility | Soluble in DMSO |
| Shelf Life | >2 years if stored properly |
| Drug Formulation | This drug may be formulated in DMSO |
| Stock Solution Storage | 0 - 4℃ for short term (days to weeks), or -20℃ for long term (months). |
| HS Tariff Code | 2934.99.9001 |